Next-generation flexible formats of VNAR domains expand the drug platform's utility and developability.

@article{Ubah2018NextgenerationFF,
  title={Next-generation flexible formats of VNAR domains expand the drug platform's utility and developability.},
  author={Obinna C. Ubah and Magdalena J Buschhaus and L. Ferguson and M. Kovaleva and J. Steven and A. Porter and C. Barelle},
  journal={Biochemical Society transactions},
  year={2018},
  volume={46 6},
  pages={
          1559-1565
        }
}
  • Obinna C. Ubah, Magdalena J Buschhaus, +4 authors C. Barelle
  • Published 2018
  • Computer Science, Medicine
  • Biochemical Society transactions
  • Therapeutic mAbs have delivered several blockbuster drugs in oncology and autoimmune inflammatory disease. Revenue for mAbs continues to rise, even in the face of competition from a growing portfolio of biosimilars. Despite this success, there are still limitations associated with the use of mAbs as therapeutic molecules. With a molecular mass of 150 kDa, a two-chain structure and complex glycosylation these challenges include a high cost of goods, limited delivery options, and poor solid… CONTINUE READING
    6 Citations
    Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review)
    • PDF
    Nanobodies as Versatile Tool for Multiscale Imaging Modalities
    • PDF

    References

    SHOWING 1-10 OF 47 REFERENCES
    The coming of age of engineered multivalent antibodies.
    • 69
    Therapeutic antibodies: successes, limitations and hopes for the future
    • 856
    Coming-of-Age of Antibodies in Cancer Therapeutics.
    • 61